Tony Brooks
CFO& VP Entrepreneurship & Commercialization @ Genome British Columbia
Tony Brooks is a seed investor at Genome British Columbia focused on Health Care and Medical Device. Tony Brooks is the CFO and VP Entrepreneurship & Commercialization at Genome British Columbia. Tony Brooks attended University of London.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Tony Brooks invests in
Stages Tony Brooks invests in
Countries Tony Brooks invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (67%)
- Medical Device 2 (67%)
- Hardware 1 (33%)
- Electronics 1 (33%)
- Water Purification 1 (33%)
Stage
- Seed 2 (67%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $2.3M / Seed / Feb 13, 2023 | ||
| Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on. | $2.5M / Seed / May 28, 2020 | ||
| Acuva Technologies is developing ultraviolet light emitting diode (UV-LED) based drinking water purification systems targeting low to moderate volumes of water in various sizes. Acuva’s reactor is a compact, modular, and scalable system comprising UV LEDs, to provide a dose of UV radiation to water flowing through the device. The UV puriicationsystem obtains germicidal destruction of biological contaminants such as viruses and bacteria. | $1M / Series B / Sep 30, 2019 |
Co-Investors
About Genome British Columbia
Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented bypartnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.
Genome British Columbia Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Tony Brooks
CFO& VP Entrepreneurship & Commercialization
|
|||
Catalina Lopez-Correa
Chief Scientific Officer & Vice President Sectors
|
|||
Federica Di Palma
Chief Scientific Officer and Vice President Sectors
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Tony Brooks invest in?
Tony Brooks invests primarily in Health Care, Medical Device and Hardware startups, most often at Seed and Series B stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tony Brooks?
Public channels for Tony Brooks include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tony Brooks last invest?
The most recent investment recorded for Tony Brooks closed in Feb 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
